Conduct of studies to evaluate the toxicity of trimethylsilyldiazomethane in laboratory animals for the National Toxicology Program (NTP)
$130,789N01FY2017ESNIH
Battelle Memorial Institute, Richland OH
Investigators
Abstract
The goal of this project is to characterize the acute toxicity of trimethylsilyldiazomethane (TMSD). TMSD is a methylating agent used in synthetic chemistry. It is marketed as a safe replacement for diazomethane, primarily due to a lower explosive potential. However, two chemists died of acute pulmonary edema while working with TMSD in the laboratory. NTP is performing toxicity studies in order to further examine the potential for TMSD to induce pulmonary toxicity. Laboratory pathology/reporting are in progress. Keywords: toxicity, inhalation, trimethylsilyldiazomethane
View original record on NIH RePORTER →